Jordan vs Mongolia: HIV/AIDS deaths averted by antiretroviral therapy
Jordan
17.47 deaths
in 2024
Mongolia
16.78 deaths
in 2024
Jordan rank
149th
Mongolia rank
150th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Jordan
- Mongolia
How they compare
Jordan currently reports 17.47 deaths against 16.78 deaths in Mongolia, a difference of 0.69 deaths.
The two have swapped places 5 times across 35 shared years of data; in 1990 it was Mongolia ahead.
Jordan ranks 149th and Mongolia ranks 150th of 157 countries.
Across the 4 decades both report, Jordan averaged higher in 1 and Mongolia in 2.
Head to head by decade
| Decade | Jordan | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 5.89 deaths | 0.4658 deaths | 5.42 deaths | Jordan |
| 2010s | 11.63 deaths | 11.81 deaths | 0.1846 deaths | Mongolia |
| 2020s | 16.33 deaths | 16.38 deaths | 0.0493 deaths | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Jordan or Mongolia?
- Jordan, at 17.47 deaths against 16.78 deaths in Mongolia as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Jordan and Mongolia?
- 0.69 deaths, with Jordan ahead.
- How many years of comparable data are there for Jordan and Mongolia?
- 35 years are reported by both, from 1990 to 2024.
- How do Jordan and Mongolia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Jordan ranks 149th and Mongolia ranks 150th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.